+852 2866 8995 General Enquiry: cs@medikonia.com | Support: support@medikonia.com

Lonza DonorPlex™ Human Hepatocytes 50 donor pool

Pooled 50-donor, mixed-gender human hepatocytes that are characterized for multiple CYP450, UGT, SULT, and transporter activities. Ideal for drug metabolite identification, characterization, and turnover kinetics. Catalog #: HUCS50P

Product description Order information Resources Panel

Product Overview

A consistent and robust source of pooled donor human hepatocytes is important for DMPK studies. With our new proprietary algorithm, we are able to predict yield, viability, and functional phenotype representing the average human populations.  The DonorPlex™ Pooled Donor Human Hepatocytes, 50 Donor, mixed-gender, is a roughly 50:50 (max 70:30) mixed gender, 50 donor pool designed to function like the average human liver.  Each batch is characterized for viable yield, and CYP1A2, CYP2A6, CYP2B6, CYP2C9, CYP2C19, CYP2E1, CYP3A4, UGT, SULT, OAT1B1/3, OCT, and NTCP activities.

With our large inventory of single donor human hepatocyte lots, and using our proprietary algorithm to predict phenotype, we can also custom produce a pooled donor hepatocyte batch with the phenotype to fit your needs. 

DonorPlex™ Pooled Donor Human Hepatocytes, 50 Donor, mixed-gender hepatocytes are ideally suited for short-term (<4hrs) in vitro drug clearance assays in a mixed gender pool.  These suspension qualified hepatocytes are not suitable for applications that require hepatocytes cultured in adhered monolayer.

 

Benefits

  • Targeted pooling method for predictable metabolism 

  • Precharacterized for 9 CYPs and 4 drug transporters

  • High viability and yields

  • Lot sizes < 2000 are possible

 

Recommended Thawing media

Lonza Human Cryopreserved Hepatocyte Thawing Medium

 

Recommended Maintenance Media

Lonza HCM™ Hepatocyte Culture Medium BulletKit™

Catalog #: HUCS50P

Please email us at cs@medikonia.com for any enquiry. To place an order, please include the catalog number(s) of the product(s) in the email.